| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,929 |
1,572 |
$772K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,374 |
1,164 |
$470K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
903 |
743 |
$402K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,833 |
4,405 |
$251K |
| 99218 |
|
252 |
186 |
$198K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,818 |
2,069 |
$191K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,041 |
838 |
$171K |
| 36415 |
Collection of venous blood by venipuncture |
6,799 |
5,463 |
$139K |
| 80053 |
Comprehensive metabolic panel |
3,238 |
2,507 |
$115K |
| 59025 |
Fetal non-stress test |
479 |
212 |
$97K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,143 |
848 |
$89K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,315 |
1,827 |
$88K |
| 76830 |
Ultrasound, transvaginal |
494 |
354 |
$84K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
499 |
327 |
$80K |
| 85027 |
|
2,294 |
1,590 |
$78K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
419 |
283 |
$77K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
494 |
293 |
$71K |
| 71046 |
Radiologic examination, chest; 2 views |
1,446 |
1,086 |
$61K |
| 86317 |
|
1,400 |
542 |
$61K |
| 80061 |
Lipid panel |
2,315 |
1,864 |
$57K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
986 |
773 |
$54K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
179 |
116 |
$53K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
594 |
449 |
$51K |
| 83735 |
|
790 |
563 |
$50K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
360 |
273 |
$50K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
634 |
290 |
$50K |
| 81001 |
|
1,431 |
1,040 |
$49K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
262 |
214 |
$46K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
360 |
264 |
$45K |
| 80076 |
|
984 |
757 |
$44K |
| 84484 |
|
374 |
237 |
$43K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
351 |
191 |
$43K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,041 |
1,421 |
$41K |
| 87081 |
|
1,787 |
1,300 |
$40K |
| 85610 |
|
1,218 |
676 |
$38K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
416 |
228 |
$35K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
294 |
208 |
$35K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
200 |
111 |
$33K |
| 88142 |
|
989 |
732 |
$31K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
395 |
241 |
$31K |
| 80306 |
|
440 |
292 |
$31K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
767 |
577 |
$28K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
764 |
575 |
$28K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
59 |
43 |
$28K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
180 |
126 |
$27K |
| 87077 |
|
877 |
657 |
$25K |
| 82728 |
|
947 |
720 |
$24K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
298 |
170 |
$24K |
| 82607 |
|
860 |
710 |
$24K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
83 |
71 |
$23K |
| 86803 |
|
741 |
536 |
$22K |
| 81003 |
|
793 |
596 |
$21K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,018 |
805 |
$21K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
516 |
383 |
$21K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
265 |
95 |
$20K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
226 |
179 |
$20K |
| 87186 |
|
636 |
491 |
$19K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
452 |
417 |
$18K |
| 84450 |
|
941 |
699 |
$17K |
| 85652 |
|
923 |
712 |
$17K |
| 83550 |
|
847 |
662 |
$17K |
| 83690 |
|
299 |
211 |
$17K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
83 |
57 |
$15K |
| 83540 |
|
877 |
690 |
$14K |
| 73630 |
|
205 |
153 |
$14K |
| 73562 |
|
118 |
90 |
$14K |
| 87088 |
|
539 |
420 |
$13K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
99 |
48 |
$13K |
| 82565 |
|
977 |
710 |
$13K |
| 86140 |
|
680 |
540 |
$13K |
| 86703 |
|
674 |
478 |
$12K |
| 70450 |
Computed tomography, head or brain; without contrast material |
93 |
81 |
$12K |
| 86901 |
|
281 |
220 |
$11K |
| 86850 |
|
286 |
226 |
$11K |
| 73610 |
|
128 |
80 |
$11K |
| 82550 |
|
237 |
184 |
$11K |
| 86900 |
|
276 |
217 |
$11K |
| 84460 |
|
772 |
557 |
$10K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
30 |
12 |
$9K |
| 87070 |
|
193 |
127 |
$9K |
| 84439 |
|
437 |
337 |
$8K |
| 82746 |
|
374 |
293 |
$8K |
| 93017 |
|
60 |
43 |
$8K |
| 84100 |
|
65 |
50 |
$7K |
| 84520 |
|
525 |
351 |
$6K |
| 83615 |
|
184 |
154 |
$6K |
| 87653 |
|
161 |
90 |
$6K |
| 85007 |
|
124 |
103 |
$6K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
115 |
99 |
$6K |
| 80055 |
|
30 |
15 |
$5K |
| 80051 |
|
309 |
211 |
$5K |
| 87340 |
|
314 |
275 |
$5K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
50 |
49 |
$5K |
| 76813 |
|
34 |
25 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
148 |
63 |
$4K |
| 72100 |
|
40 |
30 |
$4K |
| 76642 |
|
59 |
41 |
$4K |
| 82947 |
|
132 |
110 |
$4K |
| 87205 |
|
57 |
27 |
$3K |
| 85730 |
|
40 |
33 |
$3K |
| 86592 |
|
358 |
297 |
$3K |
| 84550 |
|
211 |
114 |
$3K |
| 86038 |
|
121 |
106 |
$3K |
| 71045 |
Radiologic examination, chest; single view |
14 |
12 |
$3K |
| 87075 |
|
15 |
12 |
$3K |
| 82310 |
|
209 |
129 |
$3K |
| 85379 |
|
15 |
14 |
$2K |
| 97803 |
|
16 |
12 |
$2K |
| 84153 |
|
78 |
48 |
$2K |
| 84481 |
|
96 |
37 |
$2K |
| 82950 |
|
179 |
119 |
$2K |
| 87480 |
|
65 |
52 |
$2K |
| 82043 |
|
152 |
127 |
$2K |
| 84436 |
|
49 |
45 |
$2K |
| 87660 |
|
52 |
40 |
$2K |
| 87510 |
|
52 |
40 |
$2K |
| 84702 |
|
54 |
40 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
37 |
24 |
$1K |
| 86762 |
|
57 |
49 |
$1K |
| 82150 |
|
36 |
31 |
$1K |
| 73030 |
|
19 |
13 |
$1K |
| 82247 |
|
78 |
45 |
$1K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
14 |
14 |
$968.94 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
32 |
31 |
$800.61 |
| 82570 |
|
79 |
77 |
$648.88 |
| 73502 |
|
15 |
12 |
$471.01 |
| 84075 |
|
27 |
25 |
$456.35 |
| 86706 |
|
13 |
13 |
$264.24 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
14 |
14 |
$23.47 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
16 |
14 |
$0.00 |